EXECUTIVE ENGAGEMENTS
POOL
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPANIES
* Login for a full stack data experience
DATE
OCT 2022
TABLES
122
PAGES
193
EDITION
18
PRICE
USD 5450
CODE
MCP-6829
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
What`s New for 2023?
» Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Looking Ahead to 2023
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
SELECT PLAYERS
1mg Technologies Pvt. Ltd.; Canada Drugs; DocMorris NV; Dr Fox Pharmacy; eDrugstore.com; Express Scripts Holding Company; Giant Eagle, Inc.; InternationalDrugMart.com; MediSave; Netmeds Marketplace Limited; OptumRx, Inc.; PlanetRx; Rowlands Pharmacy; The Kroger Company; Walgreen Co., ; Wal-Mart Stores, Inc.; Zur Rose Group AG
SEGMENTS
» Product (Over-the-Counter Products, Prescription Medicine)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| ePharmacy on the Roll Despite Stumbling Blocks |
| Recent Market Activity |
| Inherent Benefits of the Channel - A Key Driving Factor |
| Regulations - A Game Changer for the ePharmacy Market |
| Legal Status of Online Sale of Medications - Prescription and Non-Prescription in Select Markets |
| ePharmacies – Global Key Competitors Percentage Market Share in 2022 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 1mg Technologies Pvt. Ltd. (India) |
| Canada Drugs (Canada) |
| Dr Fox Pharmacy (UK) |
| eDrugstore.com (USA) |
| Express Scripts Holding Company (USA) |
| Giant Eagle, Inc. (USA) |
| InternationalDrugMart.com (Cyprus) |
| Lloyds Pharmacy Ltd. (UK) |
| MediSave (Canada) |
| Netmeds Marketplace Limited (India) |
| OptumRx, Inc. (USA) |
| PlanetRx (UK) |
| Rowlands Pharmacy (UK) |
| Sanicare-Apotheke (Germany) |
| T.mall.com (China) |
| The Kroger Company (USA) |
| Walgreen Co. (USA) |
| Wal-Mart Stores, Inc. (USA) |
| Yihaodian (China) |
| Zur Rose Group AG (Switzerland) |
| DocMorris NV (Netherlands) |
| 3. MARKET TRENDS & DRIVERS |
| ePharmacies Bring Potential Value to Customers |
| ePharmacies Enable Better Care and Enhance Quality of Life |
| Prescription Drugs Fuel the Growth of Electronic Pharmacies |
| Increasing Healthcare Spending in Emerging Markets: Opportunities in Store |
| Ballooning Elderly Population: The Vital Growth Driver |
| Internet Globalizes Drug Sales through ePharmacies |
| Expanding Internet User Base: A Key Driving Force |
| Rising Smartphone Usage Supports Growing Adoption |
| Re-importation or Cross Border Drug Sales: An Area of Concern in the US |
| Cyber Crime in the Name of ePharmacies on the Rise |
| Online Pharmacies Growth Leads to Global Presence of Counterfeit Drugs |
| Perils of Counterfeit and Fake Drugs |
| Operation Pangea X - A Major Crackdown against Illegal Online Pharmacies |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for ePharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for ePharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Over-the-Counter Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Over-the-Counter Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Over-the-Counter Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Prescription Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Prescription Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Prescription Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
| USA Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| JAPAN |
| ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
| Japan Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| CHINA |
| ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
| China Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| EUROPE |
| ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
| Europe Current & Future Analysis for ePharmacies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for ePharmacies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for ePharmacies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| FRANCE |
| ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
| France Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| GERMANY |
| ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
| Germany Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
| UK Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| ePharmacies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
| Asia-Pacific Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for ePharmacies by Product Segment - Over-the-Counter Products and Prescription Medicine Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for ePharmacies by Product Segment - Percentage Breakdown of Value Sales for Over-the-Counter Products and Prescription Medicine for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com